Clinical Trial Update: Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis [Phase 3]

View source ↗

Summary

A Phase 3 trial in children and adolescents evaluating maintenance therapy with Asacol (mesalamine) for Ulcerative Colitis was terminated, with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Asacol (mesalamine)

Snippet

Sponsor: Warner Chilcott | Conditions: Ulcerative Colitis | Phase 3 | Status: TERMINATED | Results posted: 2012-05-25